These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12144950)

  • 1. Effect of the amisulpride isomers on rat prolactinemia.
    Marchese G; Ruiu S; Casti P; Saba P; Gessa GL; Pani L
    Eur J Pharmacol; 2002 Jul; 448(2-3):263-6. PubMed ID: 12144950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.
    Marchese G; Ruiu S; Casti P; Bartholini F; Saba P; Gessa GL; Pani L
    Eur J Pharmacol; 2002 Jun; 447(1):109-14. PubMed ID: 12106810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the amisulpride isomers on rat catalepsy.
    Marchese G; Bartholini F; Ruiu S; Casti P; Saba P; Gessa G; Pani L
    Eur J Pharmacol; 2002 May; 444(1-2):69-74. PubMed ID: 12191584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia after low dose of amisulpride.
    Kopecek M; Bares M; Svarc J; Dockery C; Horácek J
    Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA; Erlandsson K; Spencer EP; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.
    Castelli MP; Mocci I; Sanna AM; Gessa GL; Pani L
    Eur J Pharmacol; 2001 Dec; 432(2-3):143-7. PubMed ID: 11740949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose amisulpride and elevation in serum prolactin.
    Andrade C
    J Clin Psychiatry; 2013 Jun; 74(6):e558-60. PubMed ID: 23842026
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients.
    Lee BH; Kang SG; Kim TW; Lee HJ; Yoon HK; Park YM
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):69-73. PubMed ID: 22250612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of substituted benzamides on prolactin secretion in the rat.
    Kakigi T; Maeda K; Tanimoto K; Kaneda H; Shintani T
    Biol Psychiatry; 1992 Apr; 31(8):827-31. PubMed ID: 1353691
    [No Abstract]   [Full Text] [Related]  

  • 11. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice.
    Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3507-3520. PubMed ID: 28921163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion.
    Roix JJ; DeCrescenzo GA; Cheung PH; Ciallella JR; Sulpice T; Saha S; Halse R
    Diabetes Obes Metab; 2012 Apr; 14(4):329-34. PubMed ID: 22059694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.
    Kopecek M; Bares M; Horácek J
    Neuro Endocrinol Lett; 2005 Aug; 26(4):320. PubMed ID: 16136015
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of sultopride on prolactin secretion in rats.
    Mizuchi A; Kitagawa N; Saruta S; Tokuda H; Miyachi Y
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):232-40. PubMed ID: 6424592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
    Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
    Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary.
    Huang X; Ren L; Hou L; Fan H; Wang C; Wang C; Li Y
    J Ethnopharmacol; 2020 Jul; 257():112862. PubMed ID: 32294507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.
    Akkaya C; Kaya B; Kotan Z; Sarandol A; Ersoy C; Kirli S
    J Psychopharmacol; 2009 Aug; 23(6):723-6. PubMed ID: 18562408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of dextromethorphan during pregnancy and throughout lactation prevents morphine-induced hyperprolactinemia in female rats.
    Wu LY; Huang EY; Tao PL
    Fertil Steril; 2010 Mar; 93(5):1686-94. PubMed ID: 19324339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.